Clik here to view.
ヒストソニックス®、#HOPE4LIVERピボタル試験の結果を発表
ミネアポリス （ビジネスワイヤ） — Edison®ヒストトリプシーシステムの開発および製造を行うヒストソニックス(www.histosonics.com)...
View ArticleClik here to view.
MedTech Innovator Asia Pacific Names APrevent Top 2024 Innovator in Grand...
LOS ANGELES & SINGAPORE MedTech Innovator, the largest accelerator of medical technology companies in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the...
View ArticleClik here to view.
MicroVention Rebrands to Terumo Neuro – Reflects Expanded Focus and Strategic...
ALISO VIEJO, Calif. MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro,...
View ArticleClik here to view.
MicroVention更名为Terumo Neuro以反映业务重点扩展和战略增长
加利福尼亚州，阿利索维奥 (美国商业资讯)– MicroVention, Inc.是神经血管创新领域的全球领先企业，也是Terumo Corporation的全资子公司，该公司今天宣布正式更名为Terumo Neuro，即日起生效。此次更名标志着公司的发展翻开了新的篇章，同时也将继续坚定不移地致力于创造神经血管护理领域的突破性创新成果并实现商业化。...
View ArticleClik here to view.
First of its Kind Colorectal Cancer Data from Prospective GALAXY Study...
AUSTIN, Texas Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that new data from the GALAXY arm of the ongoing CIRCULATE-Japan trial was released today...
View ArticleClik here to view.
GC Aesthetics® Launches YOUTHLY™: A New Era for Breast Implants in China
DUBLIN GC Aesthetics® (GCA), a leading medical technology company committed to advancing women’s health through innovative aesthetic and reconstructive breast solutions, is excited to announce the...
View ArticleClik here to view.
SBC Medical Group Holdings and Pono Capital Two Announce Completion of...
TOKYO & HONOLULU SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), a global owner, operator and provider of management services and products to cosmetic treatment...
View ArticleClik here to view.
GC Aesthetics®推出YOUTHLY™：中国乳房植体进入新时代
都柏林 (美国商业资讯)– GC Aesthetics® (GCA)是一家领先的医疗技术公司，致力于通过创新的乳房美容和再造解决方案提升女性健康水平。他们很高兴地宣布在中国推出YOUTHLY™品牌，该品牌的特色在于其最新的乳房植体创新成果：PERLE™、Luna XT™和The Round Collection™（100%填充）的最新版本。 通过与G&S...
View ArticleClik here to view.
Aurion Biotech在日本推出用于治疗大疱性角膜病变的Vyznova® (neltependocel)
西雅图、马萨诸塞州剑桥和东京 (美国商业资讯)– Aurion Biotech的使命是通过改变人生的再生疗法恢复数百万患者的视力，公司今天宣布开始在日本市售用于治疗大疱性角膜病变的Vyznova®（通用名称：neltependocel）。公司相信，这是第一种获批用于治疗角膜内皮疾病的细胞疗法；它已在日本获得监管和报销批准。伴随此次商业发布，日本京都府立医科大学(KPUM)的Shigeru...
View ArticleClik here to view.
Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment...
SEATTLE & CAMBRIDGE, Mass. & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced the commercial launch...
View Article